Previous 10 | Next 10 |
2024-07-04 09:00:00 ET Summary First half of 2024 is profitable for investors, S&P 500 up 14.48% and Dividend Harvesting Portfolio ROI at 14.05%. Market outlook positive with Fed rate cuts expected, unemployment increase may signal recession. Portfolio generates $1,552.82 ...
2024-07-03 11:00:15 ET Summary Merck offers strong forward earnings growth trends and a compelling current valuation, making it a GARP play with a high yield. The health care sector trades at an 18.9 forward earnings multiple, below that of the broader market. Merck's strong q...
2024-07-03 05:24:53 ET Summary Delta Air Lines stock is cheap, trading at just 7 times earnings. Its earnings grew 162% in the trailing 12-month period. Despite the COVID-19 pandemic having nearly ruined the company in 2020 and 2021, Delta's earnings increased in the trailing ...
2024-07-02 11:49:49 ET More on Moderna, Pfizer, etc. Pfizer: It Could Be A Bargain Moderna: Really Strong Competition Novavax seeks FDA authorization for updated JN.1 COVID shot Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs ...
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
2024-07-02 10:37:11 ET Summary Eaton Vance Risk-Managed Diversified Equity Income Fund offers high current income with equity exposure for income-minded investors. Inflation might be higher than official numbers suggest, making equities a good hedge; the fund's 8.90% yield compare...
2024-07-02 06:28:00 ET Pfizer (NYSE: PFE) can be a polarizing stock to own right now. Its future remains hazy given that it is facing some troubling patent cliffs and revenue from its COVID-19 vaccine is dwindling. But at the same time, the shares look cheap, and they could possess ...
2024-07-02 01:19:04 ET Summary When excluding sales Pfizer generated due to COVID-19 vaccines and medication, the business is reporting solid growth. Especially the oncology business will drive growth in the years to come, and the Seagan acquisition might also contribute. With...
2024-07-01 23:57:12 ET Summary Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P 500, Bristol-Myers has the highest potential r...
2024-07-01 14:34:13 ET Summary Beam Therapeutics Inc. is a gene editing company focused on precision genetic medicines through base editing. The company has notable collaborations with Pfizer and other pharma concerns, with several pipeline milestones in 2024. The company is m...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...